<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04498117</url>
  </required_header>
  <id_info>
    <org_study_id>QPT-ORE-005</org_study_id>
    <secondary_id>GOG-3035</secondary_id>
    <secondary_id>FLORA-5</secondary_id>
    <secondary_id>FLORA5</secondary_id>
    <nct_id>NCT04498117</nct_id>
  </id_info>
  <brief_title>Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery</brief_title>
  <acronym>FLORA-5</acronym>
  <official_title>A Multicenter Phase 3, Double-Blind, Placebo-Controlled Study Comparing Chemo-Immunotherapy (Paclitaxel-Carboplatin- Oregovomab) vs Chemotherapy (Paclitaxel-Carboplatin- Placebo) in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OncoQuest Pharmaceuticals Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gynecologic Oncology Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Iqvia Pty Ltd</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OncoQuest Pharmaceuticals Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to compare the safety and efficacy of oregovomab versus placebo, administered in&#xD;
      combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and&#xD;
      carboplatin), for the treatment of subjects with newly diagnosed advanced ovarian cancer who&#xD;
      have undergone optimal debulking.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase 3 double-blind, placebo-controlled, multi-center study to compare the safety and&#xD;
      efficacy of four administrations of oregovomab 2 mg IV versus placebo, administered in&#xD;
      combination with specific cycles of a standard six-cycle chemotherapy regimen (paclitaxel and&#xD;
      carboplatin), for the treatment of subjects with newly diagnosed ovarian cancer who have&#xD;
      undergone optimal debulking surgery and are either pending initiation of chemotherapy (Cohort&#xD;
      1 - Primary Surgery) or resumption of another three cycles of chemotherapy, having already&#xD;
      completed three cycles of neoadjuvant chemotherapy (Cohort 2 - NACT + Interval Surgery).&#xD;
&#xD;
      For Cohort 1 - Primary Surgery, 372 subjects randomized in a 1:1 ratio (i.e., chemotherapy&#xD;
      with oregovomab or chemotherapy with placebo). For Cohort 2 - NACT + Interval Surgery, 230&#xD;
      subjects will be randomized in a 1:1 ratio (i.e., chemotherapy with oregovomab or&#xD;
      chemotherapy and placebo).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 25, 2020</start_date>
  <completion_date type="Anticipated">August 26, 2027</completion_date>
  <primary_completion_date type="Anticipated">June 26, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator Assessed Progression Free Survival</measure>
    <time_frame>Date of randomization until date of first documented disease progression or date of death from any cause, whichever comes first, at up to approximately 4 years.</time_frame>
    <description>Date of randomization to radiographically-confirmed disease progression according to RECIST v1.1 as determined by the investigator or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>Date of randomization up until date of death from any cause, up to approximately 8 years</time_frame>
    <description>Date of randomization to the date of death&#xD;
Date of randomization to the date of death&#xD;
Date of randomization to the date of death</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Functional Assessment of Cancer Therapy-Ovarian Trial Outcome Index (FACT-O TOI)</measure>
    <time_frame>• Change from baseline in the global health status/QOL scale score of the FACT-O TOI, up to 4 years.</time_frame>
    <description>Physical component of quality of life (QOL) measured by a modified Functional Assessment of Cancer Therapy-Ovarian Trial Outcome Index (FACT-O-TOI).</description>
  </other_outcome>
  <other_outcome>
    <measure>NFOSI-18</measure>
    <time_frame>Change from baseline in the NFOSI-18, assessed up to 4 years.</time_frame>
    <description>Physical component of quality of life (QOL) will be measured using the FACT/NCCN Ovarian Symptom Index (FOSI).</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">602</enrollment>
  <condition>Carcinoma, Ovarian Epithelial</condition>
  <condition>Ovarian Neoplasms</condition>
  <condition>Ovarian Cancer</condition>
  <condition>Ovarian Serous Adenocarcinoma</condition>
  <condition>Fallopian Tube Neoplasms</condition>
  <condition>Fallopian Tube Adenocarcinoma</condition>
  <condition>Fallopian Tube Serous Adenocarcinoma</condition>
  <condition>Peritoneal Cancer</condition>
  <condition>Peritoneal Carcinoma</condition>
  <condition>Peritoneal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Cohort 1- Surgery Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six (6) 21-day cycles of chemotherapy with oregovomab given at four (4) cycles (Cycle 1, Cycle 3, Cycle 5, and Cycle 5 plus 12 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 1 - Primary Surgery Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Six (6) 21-day cycles of chemotherapy with placebo comparator given with chemotherapy at four (4) cycles (Cycle 1, Cycle 3, Cycle 5, and Cycle 5 plus 12 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In Cohort 2 - NACT + Interval Surgery, subjects must already have received three (3) cycles of paclitaxel and carboplatin neoadjuvant therapy. Subjects in Cohort 2 - NACT + Interval Surgery will receive three (3) cycles of chemotherapy with oregovomab given at four (4) cycles (Cycle 4, Cycle 6, Cycle 6 plus 6 weeks and Cycle 6 plus 18 weeks).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In Cohort 2 - NACT + Interval Surgery, subjects must already have received three (3) cycles of paclitaxel and carboplatin neoadjuvant therapy. Subjects in Cohort 2 - NACT + Interval Surgery will receive three (3) cycles of chemotherapy with placebo comparator given at four (4) cycles (Cycle 4, Cycle 6, Cycle 6 plus 6 weeks and Cycle 6 plus 18 weeks).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Oregovomab</intervention_name>
    <description>2 mg, dissolved in 2 mL of 0.9% Sodium Chloride Injection USP, then added to 50 mL of Sodium Chloride Injection USP infused over 20 ± 5 minutes</description>
    <arm_group_label>Cohort 1- Surgery Active</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Active</arm_group_label>
    <other_name>MAb-B43.13</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel</intervention_name>
    <description>175 mg/m^2, every 3 weeks</description>
    <arm_group_label>Cohort 1 - Primary Surgery Control</arm_group_label>
    <arm_group_label>Cohort 1- Surgery Active</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Active</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Control</arm_group_label>
    <other_name>Taxol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Carboplatin</intervention_name>
    <description>AUC 6 IV Day 1 x 6 cycles (every 21 days)</description>
    <arm_group_label>Cohort 1 - Primary Surgery Control</arm_group_label>
    <arm_group_label>Cohort 1- Surgery Active</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Active</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Control</arm_group_label>
    <other_name>Paraplatin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>2 mg, dissolved in 2 mL of 0.9% Sodium Chloride Injection USP, then added to 50 mL of Sodium Chloride Injection USP infused over 20 ± 5 minutes</description>
    <arm_group_label>Cohort 1 - Primary Surgery Control</arm_group_label>
    <arm_group_label>Cohort 2 - NACT + Interval Surgery Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Major Inclusion Criteria:&#xD;
&#xD;
          1. Adults 18 years old or older.&#xD;
&#xD;
          2. Newly diagnosed epithelial adenocarcinoma of ovarian, fallopian tube or peritoneal&#xD;
             origin FIGO Stage III or IV disease.&#xD;
&#xD;
          3. Histologic epithelial cell types: high grade serous adenocarcinoma, high grade&#xD;
             endometrioid adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma,&#xD;
             mixed epithelial carcinoma, or adenocarcinoma not otherwise specified (N.O.S.).&#xD;
&#xD;
          4. Completed debulking surgery (either primary debulking surgery or interval debulking&#xD;
             surgery at the discretion of the investigator). Debulking surgery must be optimal, R1&#xD;
             or R0 (defined as R1, macroscopic no greater than 1 cm in diameter, or R0, microscopic&#xD;
             or no evidence of tumor).&#xD;
&#xD;
          5. Preoperative serum CA- 125 levels ≥ 50 U/mL.&#xD;
&#xD;
          6. Adequate bone marrow function:&#xD;
&#xD;
               1. Absolute neutrophil count (ANC) greater than or equal to 1,500/µL&#xD;
&#xD;
               2. Platelets greater than or equal to100,000/µL&#xD;
&#xD;
               3. Hemoglobin greater than or equal to 8.0 g/dL (Note: Blood transfusion is&#xD;
                  permitted up to 48 hours before first dose of study treatment).&#xD;
&#xD;
          7. Adequate liver function:&#xD;
&#xD;
               1. Bilirubin &lt; 1.5 times upper limit normal (ULN)&#xD;
&#xD;
               2. Lactate Dehydrogenase (LDH), SGOT/AST and SGPT/ALT &lt; 2.5 times ULN&#xD;
&#xD;
               3. Albumin &gt;3.5 g/dL&#xD;
&#xD;
          8. Adequate renal function:&#xD;
&#xD;
             a. Creatinine less than or equal to1.5 times ULN&#xD;
&#xD;
          9. ECOG Performance Status of 0 or 1.&#xD;
&#xD;
        Major Exclusion Criteria:&#xD;
&#xD;
          1. BRCA1 or BRCA2 germline gene mutation test result with:&#xD;
&#xD;
               1. Positive, ambiguous or inconclusive result available within 28 days prior to&#xD;
                  starting study treatment, or&#xD;
&#xD;
               2. Known BRCA1 and BRCA2 somatic mutations, and known positive germline, or&#xD;
&#xD;
               3. Somatic Homologous Recombination Deficiency (HRD) who will receive PARP inhibitor&#xD;
                  front-line maintenance therapy.&#xD;
&#xD;
          2. Subjects with mucinous adenocarcinoma and low- grade adenocarcinoma.&#xD;
&#xD;
          3. Female subjects who are lactating and breastfeeding, or have a positive serum&#xD;
             pregnancy test within 7 days prior to the first dose of study treatment (C1D1 for&#xD;
             Cohort 1 or C4D1 for Cohort 2).&#xD;
&#xD;
          4. Active autoimmune disease, such as rheumatoid arthritis, systemic lupus erythematosus&#xD;
             (SLE), ulcerative colitis, Crohn's Disease, multiple sclerosis (MS), or ankylosing&#xD;
             spondylitis requiring active disease modifying treatment.&#xD;
&#xD;
          5. Known allergy to murine proteins or hypersensitivity to any of the excipients of the&#xD;
             oregovomab, paclitaxel, or carboplatin.&#xD;
&#xD;
          6. Chronically treated with immunosuppressive drugs such as cyclosporine,&#xD;
             adrenocorticotropic hormone (ACTH), etc. (see Appendix G).&#xD;
&#xD;
          7. Chronic therapeutic corticosteroid use, defined as &gt; 5 days of prednisone or&#xD;
             equivalent, with the exception of inhalers or those on a pre-planned steroid taper.&#xD;
             (Note: Premedication with corticosteroids per institutional standard of care is&#xD;
             allowed.)&#xD;
&#xD;
          8. Recognized acquired, hereditary, or congenital immunodeficiency disease, including&#xD;
             cellular immunodeficiencies, hypogammaglobulinemia or dysgammaglobulinemia.&#xD;
&#xD;
          9. Anticipated treatment with any other anti-cancer medications, including bevacizumab,&#xD;
             poly (ADP- ribose) polymerase (PARP) inhibitors, or any investigational agent(s)&#xD;
             during the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunil Gupta, MD, FRCPC</last_name>
    <role>Study Director</role>
    <affiliation>OncoQuest Pharmaceuticals Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Operations</last_name>
    <phone>1-780-448-1400</phone>
    <email>ClinicalTrialDisclosures@oncoquestinc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Setsuko K Chambers, MD</last_name>
      <phone>520-626-0950</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Muir Cancer Specialty Services</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
      <phone>925-674-2580</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Muir Health Clinical Research Center</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
      <phone>925-674-2580</phone>
    </contact>
    <contact_backup>
      <last_name>Peggy Newsom</last_name>
      <email>peggy.newsom@johnmuirhealth.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Southern California</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92618</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devansu S Tewari, MD</last_name>
      <phone>619-516-4075</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devansu Tewari, MD</last_name>
      <phone>619-516-4075</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Diablo Valley Oncology Hematology Medical Group</name>
      <address>
        <city>Pleasant Hill</city>
        <state>California</state>
        <zip>94523</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
    </contact>
    <contact_backup>
      <phone>(925) 674-2580</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Epic Care</name>
      <address>
        <city>Pleasant Hill</city>
        <state>California</state>
        <zip>94523</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
    </contact>
    <contact_backup>
      <phone>(925) 674-2580</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Riverside Medical Center</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Devansu Tewari, MD</last_name>
      <phone>619-516-4075</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, Davis Comprehensive Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Brooks, MD</last_name>
      <phone>916-734-5800</phone>
    </contact>
    <contact_backup>
      <phone>(916) 734-5800</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Contra Costa Oncology</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
      <phone>925-674-2580</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Muir Health Gynecologic Cancer Services</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Babak Edraki, MD</last_name>
      <phone>925-674-2580</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley Behbakht, MD</last_name>
      <phone>970-624-2500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bradley Behbakht</last_name>
      <phone>970-624-2500</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Connecticut Health Center</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Brewer, MD</last_name>
      <phone>860-679-2167</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Santin, MD</last_name>
      <phone>203-287-6200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Holloway, MD</last_name>
      <phone>407-303-6611</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Associates</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan D Indermaur, MD</last_name>
      <phone>727-821-9688</phone>
    </contact>
    <contact_backup>
      <last_name>Cheryl L Ryder, ARNP</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lewis Cancer &amp; Research Pavilion at St. Joseph's Candler</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Gill, MD</last_name>
      <phone>912-819-5704</phone>
      <email>drgills@sjchs.org</email>
    </contact>
    <investigator>
      <last_name>Sarah Gill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Women and Children/University of Hawaii</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Carney, MD</last_name>
      <phone>808-535-7545</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parkview Research Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iwona Podzielinski, MD</last_name>
      <phone>260-266-6022</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Women's Cancer Care/Mary Bird Perkins Cancer Center</name>
      <address>
        <city>Covington</city>
        <state>Louisiana</state>
        <zip>70433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Braly, MD</last_name>
      <phone>702-693-6870</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Schorge, MD</last_name>
      <phone>617-636-0156</phone>
    </contact>
    <investigator>
      <last_name>John Schorge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corrine Zarwan, MD</last_name>
      <phone>781-285-6588</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Zweizig, MD</last_name>
      <phone>508-334-5224</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Liu, MD</last_name>
      <phone>734-712-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sparrow Hospital</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Liu</last_name>
      <phone>517-364-1000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary Mercy Livonia Hospital</name>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48154</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Liu</last_name>
      <phone>734-655-4800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology - Mercy Hospital</name>
      <address>
        <city>Coon Rapids</city>
        <state>Minnesota</state>
        <zip>55433</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Thomes-Pepin, MD</last_name>
      <phone>651-735-7414</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Thomes-Pepin, MD</last_name>
      <phone>651-735-7414</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metro Minnesota Community Oncology Research Consortium</name>
      <address>
        <city>Saint Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Thomas-Pepin, MD</last_name>
      <phone>651-735-7414</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Thomes-Pepin, MD</last_name>
      <phone>651-735-7414</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nebraska Methodist Hospital</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brent Tierney</last_name>
      <phone>402-354-5250</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital (Valley Health)</name>
      <address>
        <city>Paramus</city>
        <state>New Jersey</state>
        <zip>07652</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleonora Teplinsky, MD</last_name>
      <phone>201-634-5401</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holy Name Medical Center</name>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharyn Lewin, MD</last_name>
      <phone>919-998-2279</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Womens Cancer Care Associates</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Barlin</last_name>
      <phone>518-458-1390</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center PRIME</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Nevandusky, MD</last_name>
      <phone>516-470-6901</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai - PRIME</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Cohen, MD</last_name>
      <phone>516-470-6901</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai The Blavatnik Family Chelsea Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Cohen, MD</last_name>
      <phone>212-604-6000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samanatha Cohen, MD</last_name>
      <phone>212-824-7752</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Burke</last_name>
      <phone>631-638-0836</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angeles Alvarez Secord, MD</last_name>
      <phone>919-684-3765</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke Women's Cancer Care Raleigh</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angeles Alvarez Secord, MD</last_name>
      <phone>919-684-3765</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kristine Zanotti</name>
      <address>
        <city>Chardon</city>
        <state>Ohio</state>
        <zip>44024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Zanotti, MD</last_name>
      <phone>216-844-3954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Zanotti, MD</last_name>
      <phone>216-844-3954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristin Bixel, MD</last_name>
      <phone>614-293-4969</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grandview Medical Center/Kettering Medical Center</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Reid, MD</last_name>
      <phone>937-296-7258</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>UH Minoff Health Center - Seidman</name>
      <address>
        <city>Orange Village</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Zanotti, MD</last_name>
      <phone>216-844-3954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kristine Zanotti</name>
      <address>
        <city>Westlake</city>
        <state>Ohio</state>
        <zip>44145</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristine Zanotti, MD</last_name>
      <phone>216-844-3954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Richardson, MD</last_name>
      <phone>405-271-5215</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oklahoma Cancer Specialist and Research Institution, LLC</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74146</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael A Gold, MD</last_name>
      <phone>918-505-3200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Magee Women's Hospital of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lan G Coffman, MD</last_name>
      <phone>412-647-8060</phone>
    </contact>
    <contact_backup>
      <last_name>Brenda Lee Steele, RN,CCRC,CBCN</last_name>
      <email>steeleb@upmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UPMC Hillman Cancer Center at UPMC Passavant</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15237-9643</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lan G Coffman, MD</last_name>
      <phone>412-647-8060</phone>
    </contact>
    <contact_backup>
      <last_name>Brenda Lee Steele, RN,CCRC,CBCN</last_name>
      <email>steeleb@upmc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Reading Hospital</name>
      <address>
        <city>West Reading</city>
        <state>Pennsylvania</state>
        <zip>19611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernice Robinson-Bennett, MD</last_name>
      <phone>484-628-8681</phone>
      <email>Leah.Ernst@towerhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Women &amp; Infants Hospital of Rhode Island</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Lokich, MD</last_name>
      <phone>401-453-7950</phone>
      <email>lsegal@wihri.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Research/USD-Sioux Falls</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Bell, MD</last_name>
      <phone>605-328-1368</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tennessee at Chattanooga</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen DePasquale, MD</last_name>
      <phone>423-266-3636</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Health</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy McCormick</last_name>
      <phone>254-771-4837</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health Systems</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Modesitt, MD</last_name>
      <phone>434-243-5737</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>VCU Massey Cancer Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Randall, MD</last_name>
      <phone>804-628-2341</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic Gynecological Oncology</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David A Iglesias, MD</last_name>
      <phone>540-581-0160</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MultiCare Regional Cancer Center - Auburn</name>
      <address>
        <city>Auburn</city>
        <state>Washington</state>
        <zip>98001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Breed, MD</last_name>
      <phone>253-403-7249</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Christopher</name>
      <address>
        <city>Gig Harbor</city>
        <state>Washington</state>
        <zip>98335</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Breed, MD</last_name>
      <phone>253-403-7249</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>MultiCare Regional Cancer Center - Puyallup</name>
      <address>
        <city>Puyallup</city>
        <state>Washington</state>
        <zip>98372</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Breed, MD</last_name>
      <phone>253-403-7249</phone>
    </contact>
    <contact_backup>
      <last_name>Min-Chun Chen, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MultiCare Regional Cancer Center - Tacoma</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Breed, MD</last_name>
      <phone>253-403-7249</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Hartenbach, MD</last_name>
      <phone>216-346-1739</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CEMAIC - Centro Medico Privado</name>
      <address>
        <city>Córdoba</city>
        <state>Cordoba</state>
        <zip>2941</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Emilio Salinas, MD</last_name>
      <phone>(54) 35 1476 6837</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clínica Universitaria Privada Reina Fabiola</name>
      <address>
        <city>Oncativo</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santiago Bella, MD</last_name>
      <phone>(54) 35 1414 2121</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanatorio de la Mujer</name>
      <address>
        <city>Rosario</city>
        <zip>2000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Marcela Nasurdi, MD</last_name>
      <phone>(54) 34 1449 8880</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanatorio Parque S.A</name>
      <address>
        <city>Salta</city>
        <zip>4400</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Angel Escudero, MD</last_name>
      <phone>(54) 38 7431 8800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CER San Juan Centro Polivalente de Asistencia e Inv. Clinica</name>
      <address>
        <city>San Juan</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Manuel Puig, MD</last_name>
      <phone>(54) 26 4421 1086</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinicas Viedma S.A.</name>
      <address>
        <city>Viedma</city>
        <zip>R8500</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruben Kowalyszyn</last_name>
      <phone>(54) 29 2042 2509</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>GZA Ziekenhuizen</name>
      <address>
        <city>Wilrijk</city>
        <state>Antwerp</state>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luc Dirix, MD</last_name>
      <phone>(32)34433011</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique CHC MontLégia</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryam Bourhaba</last_name>
      <phone>(32) 4224 8960</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Woluwe-Saint-Lambert</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Baurain</last_name>
      <phone>(32) 2764 1111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karla Willows, MD</last_name>
      <phone>(902) 473-3818</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>City of Health Hospital at Laval (Cité de la Santé de Laval)</name>
      <address>
        <city>Laval</city>
        <state>Quebec</state>
        <zip>H7M 3L9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Arbour-Levert, MD</last_name>
      <phone>(450) 668-1010</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUM Centre de Recherche (affiliated with University of Montreal)</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 3E4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Provencher, MD, FRCSC</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>30657</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre/Glen Site/ Royal Victoria Hospital</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Gilbert, MD</last_name>
      <phone>514-934-1934</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUS - Hôpital Fleurimont</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Bessette, MD</last_name>
      <phone>(819) 346-1110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Estudios Clínicos e Investigación Médica (CeCim)</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Saavedra, MD</last_name>
      <phone>56226965804</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro de Investigación Clínica Bradford Hill</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Rojas</last_name>
      <phone>56227357954</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sociedad de Investigaciones Medicas Limitada</name>
      <address>
        <city>Temuco</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Yañez Ruiz</last_name>
      <phone>56452982404</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prosalud</name>
      <address>
        <city>Valparaíso</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Salman Boghikian</last_name>
      <phone>56972151681</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Spacek, MD, PhD</last_name>
      <phone>42 0495834341</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Olomouc</name>
      <address>
        <city>Pavlov</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bohuslav Melichar</last_name>
      <phone>42 0588441111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Kralovske Vinohrady</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukas Rob</last_name>
      <phone>42 0267162368</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice v Motole</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Prausova, MUDr</last_name>
      <phone>42022431111</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gyorgy Bodoky</last_name>
      <phone>3614558178</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Magyar Honvedseg Egeszsegugyi Kozpont</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zsuzsanna Papai</last_name>
      <phone>3613504760</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krasznai Zoard</last_name>
      <phone>3652255705</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bacs-Kiskun Megyei Oktatokorhaz</name>
      <address>
        <city>Kecskemét</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zsolt Horvath</last_name>
      <phone>3676516700</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Socio Sanitaria Territoriale di Monza (Presidio San Gerardo)</name>
      <address>
        <city>Monza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Alberto Lissoni, MD</last_name>
      <phone>39 039 2333113</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Scambia</last_name>
      <phone>390630151</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università Campus Bio-Medico di Roma</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Angioli, MD</last_name>
      <phone>39062254145</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Center</name>
      <address>
        <city>Goyang</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Myong Cheol Lim</last_name>
      <phone>8215888110</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Beom Kim</last_name>
      <phone>82317871376</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong-Man Kim</last_name>
      <phone>8216887575</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea Univ Anam Hsp</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyong Hwa Park</last_name>
      <phone>82215770083</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min Hwan Kim</last_name>
      <phone>82222281971</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea, Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SookHee Hong</last_name>
      <phone>82215881511</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lydia Gaba Garcia, MD</last_name>
      <phone>34932275400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Francisco Grau, MD</last_name>
      <phone>34932746085</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucia Castillo Portellano</last_name>
      <phone>34958020000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICO l'Hospitalet-Hospital Duran i Reynals</name>
      <address>
        <city>L'Hospitalet De Llobregat</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatriz Pardo Burdalo</last_name>
      <phone>34932607733</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Perez Ramirez</last_name>
      <phone>34914269070</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Manuel Manso Sanchez</last_name>
      <phone>34913908000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Oncologia IVO</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Romero Noguera</last_name>
      <phone>34961114000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei county</city>
        <state>Taipei</state>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peng-Hui Wang, MD</last_name>
      <phone>88 6228712121</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cheng Kung University Hospital</name>
      <address>
        <city>Tainan</city>
        <zip>70457</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu-Fang Huang, MD</last_name>
      <phone>88 662766689</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Koo Foundation Sun Yat-Sen Cancer Center</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chi-Feng Chung, MD</last_name>
      <phone>88 6228970011</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wen-Fang Cheng, MD</last_name>
      <phone>88 6223123456</phone>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czechia</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 28, 2020</study_first_submitted>
  <study_first_submitted_qc>July 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
    <mesh_term>Cystadenocarcinoma, Serous</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
    <mesh_term>Fallopian Tube Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Oregovomab</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

